The Gastroenterology Department seeks adults ages 18-65 who have been diagnosed with moderately to severe Crohn’s Disease of >3 months duration, to test if a combination of two market-approved medications are safe and effective for the treatment of CD.
The study involves a six week screening period with tests and health assessments, including a colonoscopy. If you qualify you would receive subcutaneous study medication or placebo, with 13 clinic visits every four weeks, 2 phone visits and 2 colonoscopies. After this first phase, if you qualify and choose to participate, you may enter a long-term extension that would last approximately 4 years.
Study-related procedures, exams and medication are provided at no cost.
$167 for each completed study visit.